ISSN: 1053-8569

Journal Home

Journal Guideline

Pharmacoepidemiology and Drug Safety Q1 Unclaimed

John Wiley and Sons Ltd United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Pharmacoepidemiology and Drug Safety is a journal indexed in SJR in Epidemiology and Pharmacology (medical) with an H index of 109. It has a price of 3750 €. It has an SJR impact factor of 1,106 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,106.

Pharmacoepidemiology and Drug Safety focuses its scope in these topics and keywords: claims, regulatory, review, methods, effects, drug, fda, prescriptions, databases, data, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Categories: Pharmacology (medical) (Q1) Epidemiology (Q2)

Price

3750 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

1,106

SJR Impact factor

109

H Index

149

Total Docs (Last Year)

547

Total Docs (3 years)

5012

Total Refs

1367

Total Cites (3 years)

506

Citable Docs (3 years)

2.12

Cites/Doc (2 years)

33.64

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Clinical Microbiology Reviews Q1
The Lancet HIV Q1
Alzheimer's and Dementia Q1
European Journal of Epidemiology Q1
Journal of Clinical Epidemiology Q1

Compare this journals

Aims and Scope

Best articles by citations

Trends in prescribing for vulvovaginal candidiasis in the United States

Ovarian cancer risk and use of phenolphthalein-containing laxatives

Quality of warfarin therapy and risk of stroke, bleeding, and mortality among patients with atrial fibrillation: results from the nationwide FinWAF Registry

Antihypertensive drug therapy and the risk of lower extremity amputations in pharmacologically treated type 2 diabetes patients

Safety of anthrax vaccine: an expanded review and evaluation of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS)

Estrogen replacement therapy and risk of lung cancer

The use of a large pharmacoepidemiological database to study exposure to oral corticosteroids and risk of fractures: validation of study population and results

Uptake of COX-2 selective inhibitors and influence on NSAID prescribing in Northern Ireland

Reported adverse drug reactions and their determinants in Dutch children outside the hospital

Antihypertensive treatment is associated with improved left ventricular geometry: the Rotterdam Study

Analysis of factors associated with prescription of a potentially inappropriate combination dermatological medication among US outpatient physicians

Using community pharmacies to conduct an HSV-1 prevalence study

SHOW MORE ARTICLES

Moderate alcohol consumption and adverse drug reactions among older adults

A pharmacoeconomic comparison of misoprostol/diclofenac with diclofenac

The effectiveness of varenicline medication guide for conveying safety information to patients: a REMS assessment survey

Disproportionality analyses of spontaneous reports

The accuracy of date of death recording in the

Longitudinal patterns of new Benzodiazepine use in the elderly

Differences and over-time changes in levels of prescription opioid analgesic dispensing from retail pharmacies in Canada, 2005-2010

Potentially inappropriate medication for emergency department visits by elderly patients in Taiwan

Increasing use of ADHD medications in pregnancy

Drugs used for euthanasia in Flanders, Belgium

Reduction in the therapeutic intensity of abortive migraine drug use during ACE inhibition therapy - a pilot study

Cephalosporin utilization in the inpatient wards of a teaching hospital in Western Nepal